CERA

unofficial impact factor 1.46

Open Access Email this article to a friend

Methodological issues in assessing changes in costs pre- and post-medication switch: a schizophrenia study example

Douglas E Faries*, Allen W Nyhuis and Haya Ascher-Svanum

Cost Effectiveness and Resource Allocation 2009, 7:11 doi:10.1186/1478-7547-7-11

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.